Bdenza 40 mg Capsule

Bdenza 40 mg Capsule contains enzalutamide, an androgen receptor inhibitor used in the treatment of prostate cancer. It works by blocking androgen signals that can promote the growth of prostate cancer cells. The capsule is taken orally under the supervision of a qualified healthcare professional.

BUY NOW

Bdenza 40 mg Capsule contains 40 mg of enzalutamide and is formulated for oral administration. It is used for advanced prostate cancer, including certain non-metastatic and metastatic castration-resistant or castration-sensitive disease settings. The capsule can be taken with or without food and should be swallowed whole with water. Treatment should be prescribed and monitored by an oncology specialist based on the patient’s condition and treatment plan.

Technical Specification

Specification Details
Active Ingredient Enzalutamide 40 mg
Dosage Form Capsule
Therapeutic Class Androgen Receptor Antagonist
Main Indication Prostate Cancer
Route of Administration Oral
Storage Below 30°C

Product Also Known As

Bdenza 40 mg Capsule, Bdenza Enzalutamide 40 mg Capsule, Enzalutamide 40 mg Capsule, Enzalutamide Oral Capsule, Enzalutamide Prostate Cancer Capsule, Enzalutamide Androgen Receptor Inhibitor